TAVR as Anti-Inflammatory? An effect few imagined

We never saw it coming, such a pleiotropic effect: who would have though a mechanical device could have such a systemic anti-inflammatory effect? Transcatheter aortic valve replacement (TAVR) does in fact have it. 

TAVI como antiinflamatorio

The shear stress aortic stenosis produces activates multiple inflammatory responses mediated by monocytes. This study identified the most important mechanoreceptor, involved in the inflammatory cascade called Piezo-1. This receptor is a potentially druggable target, and although we have not yet been able to block it, we can prevent it from increasing inflammation by lowering shear stress with TAVR. 

The chance of aortic stenosis accelerating or provoking inflammation per se was unknown until now. 

TAVR has given us the unique opportunity to compare the activation status of monocytes under high shear stress (before TAVR) and under low shear stress (after TAVR).

The activation status of monocytes was determined using MAN-1 antibodies, which are specific for the activated B2 integrin Mac-1.


Read also: Computerized Tomography as First Coronary Study?


Activated monocytes adhere to stimulated endothelial cells, phagocytic activity, oxidized low density lipoproteins and cytokine expression. 

Different assays were carried out to collect this information before and after TAVR.

After TAVR, shear stress was reduced, with the resulting reduction of Mac-1 activity, cell adhesion, low density lipoprotein oxidation and inflammatory marker expression in the circulating monocytes. 


Read also: Considerations for Optimal Device Selection in TAVR.


Researchers also observed in the lab, under strictly controlled conditions, that shear stress-dependent calcium influx and monocyte adhesion are mediated by the mechanosensitive ion channel Piezo-1. 

Expression of this receptor depends on shear stress and it clearly drops after TAVR.

Conclusion

This study shows that shear stress produced by diseases such as severe aortic stenosis activates multiple monocyte functions mediated by the mechanosensitive Piezo-1. It also shows the anti-inflammatory effect of TAVR and therefore its new and unknow therapeutic benefit. 

CIRCULATIONA-A-120-045536

Original Title: Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation.

Reference: Sara Baratchi et al. Circulation. 2020;142:1092–1105.  DOI: 10.1161/CIRCULATIONAHA.120.045536.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...